X4 Pharmaceuticals Inc (XFOR)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 563k |
営業利益 | -20.15M | -25.58M | -29.3M | -25.81M | -27.21M | -25.2M | -37.29M | -33.9M |
税引前収入 | -21.6M | -29.09M | -24.02M | -55.7M | -2.28M | -19.1M | -51.75M | 90.85M |
純利益 | -21.87M | -29.1M | -24.02M | -55.71M | -2.31M | -19.13M | -51.77M | 90.83M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -20.6M | -29.33M | -29.18M | -25.6M | -27.2M | -24.99M | -37.18M | 71.25M |
EBITDA | -20.03M | -25.45M | -29.18M | -25.68M | -27.11M | -25.14M | -37.23M | -33.7M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 3.5M | 0 | 3M | 0 | 0 | 0 |
営業利益 | -24.35M | -36.13M | -45.89M | -47.8M | -59.87M | -85.11M | -88.08M | -107.52M |
税引前収入 | -22.98M | -33.88M | -43.02M | -52.81M | -61.98M | -88.68M | -93.84M | -101.09M |
純利益 | -23M | -33.92M | -43.02M | -53.4M | -62.13M | -102.64M | -96.41M | -101.17M |
優先配当 | -25k | -44k | 0 | -592k | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -44.747 | -2.373 | -2.952 | -3.311 | -3.81 | -3.649 | -0.792 | -0.605 |
EBIT | -21.89M | -32.74M | -42.79M | -51.75M | -59.13M | -84.68M | -91.77M | -106.97M |
EBITDA | -24.06M | -35.94M | -45.73M | -47.7M | -59.52M | -74.85M | -87.57M | -107.1M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約